tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TARS Stock Latest News

Promising Growth and Market Penetration of XDEMVY Drives Buy Rating and Increased Price Target
RatingsPromising Growth and Market Penetration of XDEMVY Drives Buy Rating and Increased Price Target
12d ago
TARS
Tarsus Pharmaceuticals price target raised to $88 from $72 at H.C. Wainwright
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $88 from $72 at H.C. Wainwright
12d ago
TARS
Tarsus Pharmaceuticals price target raised to $85 from $80 at BofA
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $85 from $80 at BofA
23d ago
TARS
Tarsus Pharmaceuticals’ Earnings Call Highlights XDEMVY Success
PremiumCompany Announcements
Tarsus Pharmaceuticals’ Earnings Call Highlights XDEMVY Success
3M ago
TARS
Tarsus Pharmaceuticals: Strong Sales Growth and Strategic Initiatives Drive Buy Rating
PremiumRatings
Tarsus Pharmaceuticals: Strong Sales Growth and Strategic Initiatives Drive Buy Rating
3M ago
TARS
Tarsus Pharmaceuticals: Strong Market Performance and Strategic Growth Drive Buy Rating
PremiumRatingsTarsus Pharmaceuticals: Strong Market Performance and Strategic Growth Drive Buy Rating
3M ago
TARS
Tarsus Pharmaceuticals Reports Record Sales Growth
Premium
Company Announcements
Tarsus Pharmaceuticals Reports Record Sales Growth
3M ago
TARS
Tarsus Pharmaceuticals reports Q2 EPS (48c), consensus (36c)
Premium
The Fly
Tarsus Pharmaceuticals reports Q2 EPS (48c), consensus (36c)
3M ago
TARS
Short Report: Grindr shorts at record highs as CFO quits before earnings
PremiumThe Fly
Short Report: Grindr shorts at record highs as CFO quits before earnings
3M ago
KSS
RKT
Tarsus Pharmaceuticals Holds Annual Stockholders Meeting
PremiumCompany Announcements
Tarsus Pharmaceuticals Holds Annual Stockholders Meeting
5M ago
8K
TARS
Tarsus Pharmaceuticals: Promising Outlook with Successful Xdemvy Launch and Strategic Growth Initiatives
PremiumRatings
Tarsus Pharmaceuticals: Promising Outlook with Successful Xdemvy Launch and Strategic Growth Initiatives
5M ago
TARS
Tarsus Pharmaceuticals assumed with an Outperform at Oppenheimer
PremiumThe Fly
Tarsus Pharmaceuticals assumed with an Outperform at Oppenheimer
5M ago
TARS
Promising Growth Trajectory of Tarsus Pharmaceuticals: Buy Rating Supported by Unique Product Positioning and Strong Market Presence
PremiumRatingsPromising Growth Trajectory of Tarsus Pharmaceuticals: Buy Rating Supported by Unique Product Positioning and Strong Market Presence
5M ago
TARS
Tarsus Pharmaceuticals assumed with a Buy at H.C. Wainwright
Premium
The Fly
Tarsus Pharmaceuticals assumed with a Buy at H.C. Wainwright
5M ago
TARS
Elanco sells royalty, milestone rights for Xdemvy to Blackstone for $295M
Premium
The Fly
Elanco sells royalty, milestone rights for Xdemvy to Blackstone for $295M
6M ago
BX
ELAN
Tarsus Pharmaceuticals’ Earnings Call Highlights Robust Growth
PremiumCompany Announcements
Tarsus Pharmaceuticals’ Earnings Call Highlights Robust Growth
6M ago
TARS
Tarsus Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
PremiumRatings
Tarsus Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
6M ago
TARS
Tarsus Pharmaceuticals price target raised to $84 from $78 at Guggenheim
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $84 from $78 at Guggenheim
6M ago
TARS
Tarsus Pharmaceuticals Reports Strong Q1 2025 Growth
PremiumCompany Announcements
Tarsus Pharmaceuticals Reports Strong Q1 2025 Growth
6M ago
TARS
Tarsus Pharmaceuticals reports Q1 EPS (64c), consensus (63c)
PremiumThe FlyTarsus Pharmaceuticals reports Q1 EPS (64c), consensus (63c)
6M ago
TARS
Tarsus Pharmaceuticals to present abstracts on XDEMVY at ASCRS meeting
Premium
The Fly
Tarsus Pharmaceuticals to present abstracts on XDEMVY at ASCRS meeting
6M ago
TARS
Tarsus Pharmaceuticals 2.809M share Spot Secondary priced at $44.50
Premium
The Fly
Tarsus Pharmaceuticals 2.809M share Spot Secondary priced at $44.50
8M ago
TARS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >